Clinical Trials Directory

Trials / Completed

CompletedNCT00911677

Does APOE-e4 Predict Delirium and Cognitive Dysfunction After Surgery?

Does Apolipoprotein E Genotype Predict Delirium and Postoperative Cognitive Dysfunction?

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Ottawa Hospital Research Institute · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

Patients with the APOE-ε4 genotype are at increased risk of both vascular dementia and peripheral vascular disease. Patients undergoing major vascular surgery are at particularly high risk of delirium and other, more subtle, changes in cognitive function following surgery. The hypothesis of this trial is that the APOE-ε4 genotype is associated with both delirium and postoperative cognitive dysfunction (POCD).

Conditions

Timeline

Start date
2005-08-01
Primary completion
2008-03-01
Completion
2009-05-01
First posted
2009-06-02
Last updated
2009-06-02

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00911677. Inclusion in this directory is not an endorsement.